LCM
DFTX

Laurion Capital Management’s Definium Therapeutics DFTX Stock Holding History

Laurion Capital Management’s Portfolio DFTX Stock Details DFTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-30,426
Closed -$286K – 684
2024
Q1 		$286K Buy
+30,426
New +$173K ﹤0.01% 454
2022
Q3 		– Sell
-8,822
Closed -$85K – 565
2022
Q2 		$85K Buy
+8,822
New +$112K ﹤0.01% 402

Other funds holding DFTX

CC
Commodore Capital New York $1.73B AUM 298.96% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.12B AUM 144% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
OCA
Octagon Capital Advisors New York $904M AUM 737.04% 1-Year Est. Return
Blackstone Inc
Blackstone Inc New York $25.6B AUM 26.83% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Laurion Capital Management's DFTX Position: Q2 2024 in Review

Laurion Capital Management sold out of Definium Therapeutics (DFTX) in Q2 2024, closing a stake of 30,426 shares — an estimated $286K sold.

Laurion Capital Management first reported a position in DFTX in Q2 2022 and held it in 2 quarters. The position peaked at $286K in Q1 2024. 151 funds tracked by Wall St. Rank hold DFTX as of Q2 2024.

  • Laurion Capital Management reported no remaining Definium Therapeutics position as of Q2 2024 after selling out during the quarter.
  • Laurion Capital Management sold 30,426 Definium Therapeutics shares in Q2 2024, an estimated $286K.
  • Laurion Capital Management first reported a position in Definium Therapeutics in Q2 2022 and held it in 2 quarters.
  • Laurion Capital Management's Definium Therapeutics position peaked at $286K in Q1 2024.
  • 151 funds tracked by Wall St. Rank held Definium Therapeutics as of Q2 2024.

Based on Laurion Capital Management's 13F filing for Q2 2024, filed 14 Aug 2024.